Sustaining Diabetes Shared Medical Appointments After a Pragmatic Trial
Andrea L Nederveld1, Dennis Gurfinkel2, Julia Reedy2
1From the Department of Family Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO (ALN, REG, JAW, JSH); Adult and Child Center for Outcomes Research and Delivery Science, Children's Hospital Colorado and University of Colorado Anschutz Medical Campus, Aurora, CO (DG, JR, REG. JAW, BMK, JSH); Department of Emergency Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO (BMK). andrea.nederveld@cuanschutz.edu.
Diabetes Shared Medical Appointments (SMAs) are valued but hard to sustain. Primary care teams need better reimbursement models and policy changes to ensure the long-term success of these vital diabetes self-management education and support services.
Area of Science:
- Primary Care
- Health Services Research
- Diabetes Management
Background:
- Diabetes Shared Medical Appointments (SMAs) offer diabetes self-management education and support (DSMES) in primary care settings.
- Sustaining SMAs after initial implementation presents significant challenges for primary care practices.
Purpose of the Study:
- To understand factors influencing the sustainability of diabetes SMAs from the perspective of primary care practice members.
- To identify barriers and facilitators for long-term implementation of SMAs following a pragmatic trial.
Main Methods:
- A qualitative study involving 79 interviews with members of 20 primary care practices that participated in the Invested in Diabetes pragmatic trial.
- Analysis employed a grounded theory hermeneutic editing approach to explore experiences and perspectives on SMA sustainability.
Main Results:
- SMAs were perceived as valuable, yet sustainability plans were inconsistent across practices.
- Key themes for sustainability included practical operational factors (some unsupported by current payment models), the need for relevance and efficiency, and the incentive of improved quality measures.
Conclusions:
- Primary care teams are motivated to provide diabetes SMAs, but sustainability is hindered by current healthcare reimbursement structures.
- Policy changes, healthcare payment innovation, and novel reimbursement models are crucial for enhancing the sustainability of SMAs and improving patient outcomes.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Chronic Pancreatitis II: Collaborative Care
Assessment:
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...


